Eli Lilly Ends Antibody Trial In Hospitalized COVID-19 Patients, Other Trials Go On
The trial studied the efficacy of bamlanivimab in combination with the antiviral remdesivir on hospitalized COVID-19 patients. Researchers concluded the antibody treatment was "unl…